Form EFFECT PLIANT THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 6, 2026 4:15 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FMC Corporation announces date for third quarter 2026 earnings release and webcast conference call
- newcleo Completes Business Combination, Raises $247 Million and Will Start Trading on Nasdaq Under Ticker Symbol “NWCL” on September 22, 2026
- Arthur Hu to Join BD as Chief Information and Digital Officer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
